Due to the intricate inter-relationship and the high global prevalence of NAFLD and T2DM, targeting insulin sensitivity and hyperglycemia combined with weight loss and adopting a holistic approach to the treatment of metabolic disease in patients with NAFLD could prove advantageous. The gene discussed is INS; the disease is type 2 diabetes mellitus.